ClinicalTrials HQ

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

Recruiting · NCT07659782 · Registry updated 2026-10-07
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22026-10-07NCT07659782

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Verastem, Inc.24

19 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
BRCR Global- San JuanSan JuanPuerto Rico1
BRCR Global- TamaracTamaracUnited States1
BRCR Global- YaucoYaucoPuerto Rico1
Cedars-Sinai Medical CenterLos AngelesUnited States392
Chris O'Brien LifehouseCamperdownAustralia46
Emory Winship Cancer InstituteAtlantaUnited States29
ICON Cancer Centre South BrisbaneBrisbaneAustralia3
Macquarie University HospitalSydneyAustralia9
MD Anderson Cancer CenterHoustonUnited States589
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Moffit Cancer CentreTampaUnited States1
NYUNew YorkUnited States3
START Fort WorthFort WorthUnited States1
START LALos AngelesUnited States1
START New JerseyEast BrunswickUnited States16
University of UtahSalt Lake CityUnited States137
University of VirginiaCharlottesvilleUnited States122
Valkyrie Clinical TrialsLos AngelesUnited States47
Virginia Cancer SpecialistsFairfaxUnited States109